[HTML][HTML] The unfolded protein response-glutathione metabolism axis: A novel target of a cycloruthenated complexes bypassing tumor resistance mechanisms
G Riegel, C Orvain, S Recberlik, ME Spaety, G Poschet… - Cancer Letters, 2024 - Elsevier
Platinum-based drugs remain the reference treatment for gastric cancer (GC). However, the
frequency of resistance, due to mutations in TP53 or alterations in the energy and redox …
frequency of resistance, due to mutations in TP53 or alterations in the energy and redox …
The unfolded protein response-glutathione metabolism axis: A novel target of a cycloruthenated complexes bypassing tumor resistance mechanisms.
G Riegel, C Orvain, S Recberlik, ME Spaety… - Cancer Letters, 2024 - europepmc.org
Platinum-based drugs remain the reference treatment for gastric cancer (GC). However, the
frequency of resistance, due to mutations in TP53 or alterations in the energy and redox …
frequency of resistance, due to mutations in TP53 or alterations in the energy and redox …
The unfolded protein response-glutathione metabolism axis: A novel target of a cycloruthenated complexes bypassing tumor resistance mechanisms
G Riegel, C Orvain, S Recberlik, ME Spaety… - Cancer … - pubmed.ncbi.nlm.nih.gov
Platinum-based drugs remain the reference treatment for gastric cancer (GC). However, the
frequency of resistance, due to mutations in TP53 or alterations in the energy and redox …
frequency of resistance, due to mutations in TP53 or alterations in the energy and redox …